Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Original languageUndefined/Unknown
JournalScientific Reports
DOIs
Publication statusPublished - Oct 2018

Cite this